Company: PTHS
Filing Date: 2025-09-16
Form Type: 8-K/A
Source: 0001753926-25-001500
Chunk: 149

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-09-16
Form: 8-K/A
Chunk 149
---
 costs related to preventive maintenance associated with equipment of $0.5 million.

Selling, general and administrative expense was $16.6 million during the six months ended June 30, 2025, an increase of $9.6 million, or 135%, compared to $7.1 million for the six months ended June 30, 2024. The increase in selling, general and administrative expense was primarily attributable to a $5.0 million milestone owed to Ligand related to ZELSUVMI commercialization activities, commercialization work, including marketing and education materials and conference costs, totaling $1.7 million.

Amortization of intangibles was $162 thousand during the six months ended June 30, 2025, a decrease of $195 thousand, or 55%, compared to $357 thousand for the six months ended June 30, 2024. The decrease in amortization of intangibles was related to the transfer of the intangible asset for the NITRICIL technology from LNHC to Ligand in March 2025.

Other income (expense)

|                                   |     | Three months ended |      |   |     |      |      |   |     | Six months ended |        |   |     |      |      |   |
|                                   |     |           June 30, |      |   |     |      |      |   |     |         June 30, |        |   |     |      |      |   |
| (Dollars in thousands)            |     |               2025 |      |   |     | 2024 |      |   |     |             2025 |        |   |     | 2024 |      |   |
| Other income (expense), net:      |     |                    |      |   |     |      |      |   |     |                  |        |   |     |      |      |   |
| Interest expense                  |     |                  $ | (930 | ) |     |    $ | (380 | ) |     |                $ | (1,556 | ) |     |    $ | (750 | ) |
| Other income (expense)            |     |                    | (26  | ) |     |      |    2 |   |     |                  | (49    | ) |     |      | (4   | ) |
| Total other income (expense), net |     |                  $ | (956 |